Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

OrthoPediatrics Corp. Expands Specialty Bracing Portfolio with DF2® Brace

WARSAW, Ind., Nov. 26, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company dedicated exclusively to advancing the field of pediatric orthopedics, is excited to announce significant updates to the DF2® Brace, a cornerstone product within the OrthoPediatrics Specialty Bracing business (“OPSB”). The DF2 Brace updates include expanded indications for use, enhanced sizing options, and additional international markets.

The DF2 Brace, which has seen strong adoption in the U.S. as an alternative to traditional spica casting, is now indicated for post-operative stabilization in addition to its use for femur fracture fixation. The brace also offers extended sizing options, including XS, S, M, L, XL, and XXL, to meet the needs of a broader patient population.

Building on its domestic success, the DF2 Brace has now been launched in Europe, the Middle East, and Asia-Pacific markets. The OPSB leadership team achieved this milestone by accelerating regulatory and hospital approvals and leveraging robust support from key opinion leaders outside the United States. These efforts underscore the Company’s commitment to making the DF2 Brace accessible to pediatric orthopedic surgeons globally.

Joe Hauser, President of OrthoPediatrics Trauma, Deformity Correction and Specialty Bracing divisions commented, “These updates represent the successful execution of our larger overall strategy, and I am proud that we have expanded indications for use, enhanced the sizing options, and launched in additional international markets with this product. The DF2 Brace highlights our commitment to advancing care for kids by providing an alternative to spica casting that is a huge improvement in the quality of life for patients and their families. With its expanded indications and availability in new markets, we are excited about the opportunities this innovation creates to improve outcomes for young patients worldwide. We have a robust pipeline of development projects, and our team will continue bringing innovative solutions to our customers for non-operative care through the OP Specialty Bracing division and we look forward to future milestones such as this.”

Product Indications:
The DF2 Brace is intended for femur fracture fixation and post-operative stabilization in pediatric patients approximately 6 months to 5 years of age. It provides immobilization of the femur, knee, and hip, offering a modern solution that enhances patient care and recovery.

About OrthoPediatrics Corp.
Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets over 70 products that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and over 70 countries outside the United States. For more information, please visit www.orthopediatrics.com. For more information about the DF2® Brace and OrthoPediatrics’ Specialty Bracing portfolio, please visit https://opsb.com/.

Investor Contact
Philip Trip Taylor
Gilmartin Group
philip@gilmartinir.com
415-937-5406


Primary Logo

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.